9 Specific Ways Menopause and HRT Raise Your Gallstone Risk — and What to Do About It
Nobody warned me that the same hormones protecting my bones might be quietly stirring up trouble in my gallbladder. When a friend ended up in surgery two years into HRT, her doctor shrugged and said it was 'just one of those things.' It isn't — there are real mechanisms at work here, and real things women can do. That's why this page exists.
Learn more about Rose →Falling Estrogen Makes Bile More Lithogenic
Estrogen, at physiological levels, helps keep bile fluid and less prone to forming crystals. When estrogen drops at menopause, the balance between cholesterol and bile salts shifts, producing bile that is supersaturated with cholesterol — the exact condition in which gallstones form. This change begins in perimenopause and worsens progressively after the final period.
Oral Estrogen Passes Through the Liver and Alters Bile Composition
When estrogen is taken orally — as a pill rather than a patch or gel — it is absorbed via the gut and travels directly to the liver before entering the bloodstream, a process called first-pass metabolism. This concentrated hepatic exposure causes the liver to secrete more cholesterol into bile while reducing bile acid output, a combination that dramatically increases stone-forming potential. Multiple large studies, including the Women's Health Initiative, have confirmed that oral estrogen significantly increases gallbladder disease risk, while transdermal routes show a much smaller or negligible effect.
Progesterone Slows Gallbladder Emptying
Progesterone — both endogenous and the synthetic progestogens used in HRT — relaxes smooth muscle, including the muscle of the gallbladder wall. A sluggish gallbladder doesn't empty efficiently after meals, allowing bile to pool and concentrate, which gives cholesterol crystals more time to nucleate and grow into stones. This effect is one reason gallstone risk is also elevated during pregnancy, when progesterone levels are very high.
Menopause-Related Weight Gain Increases Cholesterol Secretion Into Bile
The fat redistribution that accompanies menopause — more visceral fat around the abdomen — is metabolically active and increases the liver's output of cholesterol, including into bile. Higher biliary cholesterol is a direct precursor to cholesterol gallstones, the most common type in Western women. Even modest weight gain of 4–5 kg during the menopause transition meaningfully raises this risk.
Insulin Resistance Impairs Bile Acid Metabolism
Insulin resistance, which becomes more common after menopause, disrupts the signalling pathways that regulate bile acid synthesis and recycling in the gut-liver axis. When bile acid cycling is impaired, the relative proportion of cholesterol in bile rises, and gallbladder contractility is further blunted. Women who develop metabolic syndrome during or after menopause carry a substantially higher gallstone burden than metabolically healthy peers.
Rapid Weight Loss — Common During HRT Initiation or Dieting — Can Trigger Stone Formation
When calorie intake drops sharply or weight loss is fast, the liver secretes extra cholesterol into bile as it metabolises fat stores, while the gallbladder empties less frequently due to reduced fat intake stimulating cholecystokinin release. This is a well-established gallstone trigger, and it is particularly relevant for women who start HRT alongside a new diet or weight-loss programme. The protective strategy is gradual, sustained weight loss rather than aggressive restriction.
Low Dietary Fat Reduces the Hormonal Signal That Empties the Gallbladder
Dietary fat triggers the release of cholecystokinin, the hormone that signals the gallbladder to contract and push bile into the small intestine. Very low-fat diets — which some women adopt during menopause for cardiovascular reasons — reduce this signal, meaning the gallbladder sits full for longer between contractions. Paradoxically, including modest amounts of healthy fat at each meal (olive oil, nuts, avocado) actually helps protect the gallbladder by keeping it regularly emptied.
Declining Physical Activity After Menopause Slows Gut Motility and Bile Cycling
Regular physical activity stimulates gut motility, which in turn speeds up the enterohepatic cycling of bile acids — the loop by which bile acids are reabsorbed in the gut, returned to the liver, and resecretted. When activity levels drop, this cycle slows, bile acids spend longer in the colon, and the liver compensates by pulling more cholesterol into bile. Studies in postmenopausal women consistently show that physically active women have lower rates of gallbladder disease than sedentary peers.
Transdermal HRT and Micronised Progesterone Carry a Meaningfully Lower Risk — but Women Are Rarely Offered the Choice Proactively
The evidence is now consistent enough that the route of estrogen delivery is the most actionable single variable for gallbladder risk: transdermal estrogen (patch, gel, or spray) bypasses liver first-pass metabolism almost entirely and has not been shown to significantly increase gallstone risk in large observational studies. Similarly, micronised progesterone (body-identical) appears to have less impact on gallbladder motility than older synthetic progestogens. Women with existing gallbladder disease, obesity, or a family history of gallstones have particularly strong grounds to discuss transdermal options with their prescriber — a conversation many are never offered.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.